unknown
Stage
1
Investors
About
Angstrom Bio develops diagnostic technologies using amplicon sequencing combined with machine learning to improve precision medicine and human health outcomes.
Explore Angstrom Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.